Log In
Print this Print this

BAY 1125976

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionAllosteric protein kinase B (PKB; AKT1) and protein kinase B beta (PKBB; AKT2) inhibitor
Molecular Target Protein kinase B (AKT) (AKT1) (PKB) (PKBA) ; Protein kinase B beta (AKT2) (PKBB)
Mechanism of ActionProtein kinase B (PKB) (AKT1) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today